Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes

Author:

Arendrup Maiken Cavling123ORCID,Jørgensen Karin Meinike1,Guinea Jesus45ORCID,Lagrou Katrien67,Chryssanthou Erja8,Hayette Marie-Pierre9,Barchiesi Francesco1011,Lass-Flörl Cornelia12,Hamal Petr13,Dannaoui Eric14,Chowdhary Anuradha15,Meletiadis Joseph16ORCID

Affiliation:

1. Unit for Mycology, Statens Serum Institut, Copenhagen, Denmark

2. Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark

3. Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark

4. Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain and Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

5. CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain

6. Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

7. Department of Laboratory Medicine and National Reference Centre for Mycosis, University Hospitals Leuven, Leuven, Belgium

8. Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden

9. Department of Clinical Microbiology, Centre for Interdisciplinary Research on Medicines, University of Liège, Liège, Belgium

10. Dipartimento di Scienze Biomediche e Sanità Pubblica, Università Politecnica delle Marche, Ancona, Italy

11. Malattie Infettive, Ospedali Riuniti Marche Nord, Pesaro, Italy

12. Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria

13. Department of Microbiology, University Hospital, Olomouc, Czech Republic

14. Parasitology-Mycology Unit, Microbiology Department, Georges Pompidou European Hospital, University of Paris, Paris, France

15. Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India

16. Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Abstract

Abstract Objectives Terbinafine resistance is increasingly reported in Trichophyton, rendering susceptibility testing particularly important in non-responding cases. We performed a multicentre evaluation of six EUCAST-based methods. Methods Ten laboratories susceptibility tested terbinafine, itraconazole, voriconazole and amorolfine against a blinded panel of 38 terbinafine WT and target gene mutant isolates. E.Def 9.3.1 modifications included: medium with/without addition of chloramphenicol and cycloheximide (CC), incubation at 25°C to 28°C for 5–7 days and three MIC endpoints [visually and spectrophotometrically (90%/50% inhibition)], generating 7829 MICs. Quality control (QC) strains were Aspergillus flavus ATCC 204304 and CNM-CM1813. Eyeball, ECOFFinder (where ECOFF stands for epidemiological cut-off) and derivatization WT upper limits (WT-ULs), very major errors (VMEs; mutants with MICs ≤WT-ULs) and major errors (MEs; WT isolates with MICs >WT-ULs) were determined. Results MICs fell within the QC ranges for ATCC 204304/CNM-CM1813 for 100%/96% (voriconazole) and 84%/84% (itraconazole), respectively. Terbinafine MICs fell within 0.25–1 mg/L for 96%/92%, suggesting high reproducibility. Across the six methods, the number of terbinafine MEs varied from 2 to 4 (2.6%–5.2%) for Trichophyton rubrum and from 0 to 2 (0%–2.0%) for Trichophyton interdigitale. Modes for WT and mutant populations were at least seven 2-fold dilutions apart in all cases. Excluding one I121M/V237I T. rubrum mutant and two mixed WT/mutant T. interdigitale specimens, the numbers of VMEs were as follows: T. rubrum: CC visual, 1/67 (1.5%); CC spectrophotometric 90% inhibition, 3/59 (5.1%); and CC spectrophotometric 50% inhibition, 1/67 (1.5%); and T. interdigitale: none. Voriconazole and amorolfine MICs were quite uniform, but trailing growth complicated determination of itraconazole visual and spectrophotometric 90% inhibition MIC. Conclusions Although none of the laboratories was experienced in dermatophyte testing, error rates were low. We recommend the CC spectrophotometric 50% inhibition method and provide QC ranges and WT-ULs for WT/non-WT classification.

Funder

Ministry of Health of the Czech Republic

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3